Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
06 2023
Historique:
medline: 18 5 2023
pubmed: 26 1 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

White matter (WM) injury is frequently observed along with dementia. Positron emission tomography with amyloid-ligands (Aβ-PET) recently gained interest for detecting WM injury. Yet, little is understood about the origin of the altered Aβ-PET signal in WM regions. Here, we investigated the relative contributions of diffusion MRI-based microstructural alterations, including free water and tissue-specific properties, to Aβ-PET in WM and to cognition. We included a unique cohort of 115 participants covering the spectrum of low-to-severe white matter hyperintensity (WMH) burden and cognitively normal to dementia. We applied a bi-tensor diffusion-MRI model that differentiates between (i) the extracellular WM compartment (represented via free water), and (ii) the fiber-specific compartment (via free water-adjusted fractional anisotropy [FA]). We observed that, in regions of WMH, a decrease in Aβ-PET related most closely to higher free water and higher WMH volume. In contrast, in normal-appearing WM, an increase in Aβ-PET related more closely to higher cortical Aβ (together with lower free water-adjusted FA). In relation to cognitive impairment, we observed a closer relationship with higher free water than with either free water-adjusted FA or WM PET. Our findings support free water and Aβ-PET as markers of WM abnormalities in patients with mixed dementia, and contribute to a better understanding of processes giving rise to the WM PET signal.

Identifiants

pubmed: 36695071
doi: 10.1177/0271678X231152001
pmc: PMC10196746
doi:

Substances chimiques

Water 059QF0KO0R

Banques de données

ClinicalTrials.gov
['NCT02330510']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

921-936

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States

Références

Neuroimage. 2014 May 15;92:27-35
pubmed: 24503415
Neuropathol Appl Neurobiol. 2007 Aug;33(4):410-9
pubmed: 17442062
Stroke. 2014 Jun;45(6):1721-6
pubmed: 24781079
Neuroimage. 2011 Apr 1;55(3):880-90
pubmed: 21182970
Micron. 2004;35(7):503-42
pubmed: 15219899
Neuroimage. 2011 Jan 15;54(2):963-73
pubmed: 20849961
J Nucl Med. 2018 Oct;59(10):1583-1589
pubmed: 29674420
Ann Clin Transl Neurol. 2019 Mar 03;6(4):678-688
pubmed: 31019992
J Neuropathol Exp Neurol. 2017 Apr 1;76(4):299-312
pubmed: 28431180
Ann Neurol. 2022 Dec;92(6):992-1000
pubmed: 36054513
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neuroimage. 2015 Mar;108:450-9
pubmed: 25482269
Magn Reson Med. 2009 Sep;62(3):717-30
pubmed: 19623619
J Nucl Med. 2022 Aug;63(8):1239-1244
pubmed: 34916245
Hum Brain Mapp. 2022 May;43(7):2089-2108
pubmed: 35088930
Ann Neurol. 2011 Apr;69(4):673-80
pubmed: 21337603
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1242-1253
pubmed: 34581847
Front Neurosci. 2020 Dec 14;14:598868
pubmed: 33381009
Alzheimers Res Ther. 2022 Feb 12;14(1):33
pubmed: 35151361
Neurology. 2018 Jun 12;90(24):e2119-e2126
pubmed: 29769375
JAMA Neurol. 2014 Jan;71(1):23-31
pubmed: 24217171
Sci Rep. 2021 Mar 26;11(1):6990
pubmed: 33772083
Brain. 2008 Mar;131(Pt 3):665-80
pubmed: 18263627
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407
pubmed: 24647577
Acta Neuropathol. 1997 Apr;93(4):334-40
pubmed: 9113198
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
J Nucl Med. 2017 Aug;58(8):1285-1292
pubmed: 28062596
Brain Commun. 2022 Jun 06;4(3):fcac142
pubmed: 35694147
Neuroimage. 2012 Jan 16;59(2):1394-403
pubmed: 21924365
J Magn Reson Imaging. 2019 Feb;49(2):456-465
pubmed: 30635988
Neurology. 1995 Nov;45(11):2077-84
pubmed: 7501162
J Neurosci. 2012 Nov 28;32(48):17365-72
pubmed: 23197727
Neuroscience. 2014 Sep 12;276:14-28
pubmed: 24051366
Neuroradiology. 2018 Sep;60(9):933-944
pubmed: 30030550
J Nucl Med. 2009 Nov;50(11):1887-94
pubmed: 19837759
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Front Neurol. 2020 Oct 16;11:541377
pubmed: 33178101
Am J Pathol. 2004 Aug;165(2):357-71
pubmed: 15277212
J Nucl Med. 2017 Sep;58(9):1483-1489
pubmed: 28336779
Neuroimage Clin. 2013 Jul 27;3:180-95
pubmed: 24179862
Brain. 2013 Sep;136(Pt 9):2697-706
pubmed: 23842566
Neuroinformatics. 2021 Oct;19(4):597-618
pubmed: 33527307
PLoS One. 2017 Dec 6;12(12):e0189155
pubmed: 29211812
J Nucl Med. 2019 Oct;60(10):1444-1451
pubmed: 30877180
J Alzheimers Dis. 2018;62(4):1595-1607
pubmed: 29504529
Mol Med. 2003 Mar-Apr;9(3-4):112-22
pubmed: 12865947
Alzheimers Res Ther. 2017 Aug 17;9(1):63
pubmed: 28818116
J Nucl Med. 2015 Apr;56(4):567-74
pubmed: 25745095
Eur J Neurol. 2013 Feb;20(2):243-50
pubmed: 22742818
Neuroimage Clin. 2015 Sep 29;9:479-83
pubmed: 26594630
Alzheimers Dement. 2018 Jun;14(6):764-774
pubmed: 29406155
Stroke. 2015 Jan;46(1):262-4
pubmed: 25395414
JAMA Neurol. 2017 Jan 01;74(1):41-49
pubmed: 27842175
Neurology. 2017 Mar 14;88(11):1077-1080
pubmed: 28202707
AJNR Am J Neuroradiol. 2006 Sep;27(8):1717-24
pubmed: 16971621
Neurobiol Aging. 2015 Feb;36(2):909-18
pubmed: 25457555
Alzheimers Dement. 2023 Apr;19(4):1503-1517
pubmed: 36047604
Neurology. 2019 May 7;92(19):e2221-e2231
pubmed: 30952798
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):515-26
pubmed: 26550542
Acta Neuropathol Commun. 2014 Aug 17;2:83
pubmed: 25129614
J Nucl Med. 2009 Feb;50(2):198-204
pubmed: 19164220

Auteurs

Julie Ottoy (J)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Miracle Ozzoude (M)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Katherine Zukotynski (K)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Departments of Medicine and Radiology, McMaster University, Hamilton, ON, Canada.
Department of Medical Imaging, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
Department of Radiology, University of British Columbia, Vancouver, BC, Canada.

Min Su Kang (MS)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Sabrina Adamo (S)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Christopher Scott (C)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Joel Ramirez (J)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Walter Swardfager (W)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.

Benjamin Lam (B)

Department of Medicine (Division of Neurology), Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Research Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Aparna Bhan (A)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Parisa Mojiri (P)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Alex Kiss (A)

Department of Research Design and Biostatistics, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Stephen Strother (S)

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
The Rotman Research Institute Baycrest, University of Toronto, Toronto, ON, Canada.

Christian Bocti (C)

Service de Neurologie, Département de Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada.

Michael Borrie (M)

Lawson Health Research Institute, Western University, London, ON, Canada.

Howard Chertkow (H)

Jewish General Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Richard Frayne (R)

Departments of Radiology and Clinical Neuroscience, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Robin Hsiung (R)

Physics and Astronomy Department and DM Center for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Robert Jr Laforce (RJ)

Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, QC, Canada.

Michael D Noseworthy (MD)

Departments of Medicine and Radiology, McMaster University, Hamilton, ON, Canada.
Department of Electrical and Computer Engineering, McMaster University, Hamilton, ON, Canada.

Frank S Prato (FS)

Lawson Health Research Institute, Western University, London, ON, Canada.

Demetrios J Sahlas (DJ)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Eric E Smith (EE)

Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Phillip H Kuo (PH)

Department of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, AZ, USA.

Jordan A Chad (JA)

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
The Rotman Research Institute Baycrest, University of Toronto, Toronto, ON, Canada.

Ofer Pasternak (O)

Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

Vesna Sossi (V)

Physics and Astronomy Department and DM Center for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Alexander Thiel (A)

Jewish General Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Jean-Paul Soucy (JP)

Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Jean-Claude Tardif (JC)

Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.

Sandra E Black (SE)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Department of Medicine (Division of Neurology), Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Research Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Maged Goubran (M)

LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Physical Sciences Platform, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH